Skip to main content
Caplight Logo









Jellagen

Jellagen

Private
CardiffHealthcare & Life Scienceshttps://jellagen.co.uk/

Last Round

Series A

Dec 7, 2022

Total Funding Raised

$21.52M

Company Overview

Jellagen is a biotechnology company that develops and manufactures medical-grade Collagen Type 0 from jellyfish for use in tissue engineering and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

collagen type 0jellyfish collagennon-mammalian collagenregenerative medicinetissue engineeringmedical grade collagenbiomaterials3D cell culturehydrogelwound care3D scaffoldsmarine collagensustainable biomaterialsbio inkmedical device components

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jellagen Comparables

Compare Jellagen with similar companies based on industry and business-model similarity.

Jellagen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Symatese
74%
Evergen
73%
CollPlant Biotechnologies Ltd.
73%

Jellagen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 7, 2022
SeedJun 25, 2020
SeedMay 3, 2018
SeedApr 6, 2016
GrantMay 1, 2015
Grant
Oct 17, 2014

Key People

Founding team and executive leadership

Thomas-Paul Descamps

CEO

Executive Team

Jellagen Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 148% MoM, reaching 1.6K.

  • Jan 6, 2026

    Monthly visitors grew 374% MoM, reaching 3.1K.

Jellagen Filings

Explore SEC and related filing metadata, where available.

Jellagen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Jellagen's valuation, stock price, and market status.

Is Jellagen a public or private company?

Jellagen is a private company.

What is the current stock price of Jellagen?

Jellagen is a private company with no public stock price. No recent secondary market data is available.

How much is Jellagen worth (valuation)?

Valuation information for Jellagen is not publicly available.

Can I buy Jellagen stock?

Jellagen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Jellagen's last funding round?

Jellagen's most recent funding round was Series A on December 7, 2022.

Who are the main investors in Jellagen?

Key investors in Jellagen include Cardiff Capital Region, Newable Private Investing, Innovate UK, Angels in MedCity, Development Bank of Wales.

Will Jellagen IPO soon?

No public IPO plans have been announced for Jellagen.

How can I track Jellagen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Jellagen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCardiff
Employee Range12
Year Founded2015
Last FundingDec 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?